(84 Total References)
Employee Reviews | Colleague Reviews | Coworker Reviews | Manager Reviews | Hallway.com
www.hallway.com, 12 July 2011 [cached]
Budimir S. Drakulic Ph.D Chief Scientist and Director of Research & Development , Signalife Inc.
Budimir S. ...
www.crmz.com, 15 June 2008 [cached]
Budimir S. DrakulicChief Technology OfficerSignalife Inc.
Recom Managed Systems - Management Team
www.recom-systems.com, 27 Feb 2006 [cached]
Budimir S. Drakulic, PhD: Chief Technical Officer & Chief ScientistDr. Drakulic has 25 years of experience in the design and development of sophisticated hardware/software biomedical microelectronic systems.He was Chief Scientist of Teledyne Electronics Technologies Medical Device Division and Director of Microelectronic Development Laboratory at Crump Institute (UCLA).He is the recipient of the Ralph and Marjorie Crump Prize for Excellence in Medical Engineering from UCLA in 1985 while a Research Fellow with the Crump Institute for Medical Engineering at UCLA.
Includes 600,000 common shares held by ...
www.sec.gov, 19 May 2004 [cached]
Includes 600,000 common shares held by B World Technologies, Inc. and 234,375 common shares issuable upon exercise of options granted to B World Technologies in connection with services performed by Dr. Drakulic.Both B World Technologies and B Technologies are owned and controlled by Dr. Drakulic
...On October 11, 2002, Recom reached an agreement-in-principle with Dr. Budimir Drakulic to become our Vice President and Chief Technology Officer on a consulting basis through his consulting companies.
Pursuant to that understanding, on October 15, 2002, we entered into a loan-out agreement with B World Technologies, Inc.
and B Technologies, Inc.
relative to the provision of Dr. Drakulic's services, which formally commenced as of that date.Dr. Drakulic is the president and owner of these companies.
...B World Technologies
was granted 600,000 "restricted" common shares (200,000 shares pre-split), to be earned over five years of continuous provision of services by Dr. Drakulic
Since March 1, 2003, Dr. Drakulic
has worked for us on a full-time basis even though the loan-out agreement only provides for the provision of part-time services.We have agreed to characterize these additional services as being provided by Dr. Drakulic
as an employee, and to pay him $7,500 annually as compensation for their provision.On March 10, 2003, as additional incentive for the performance of Dr. Drakulic
, we granted to B World Technologies options entitling it to purchase 750,000 common shares at $0.95 per share.These options vest quarterly over a four year term, and lapse, if not exercised, on March 9, 2008.Concurrent with entering into the loan-out agreement, B World Technologies
, B Technologies
and Dr. Drakulic
signed an employment, confidential information, invention assignment and arbitration agreement under which they agreed, among other things, to assign to us all of Dr. Drakulic's right, title and interest in and to any and all inventions, discoveries, etc. which he
conceives or develops while engaged by Recom
Heart Tronics, Inc. | Clear Data. Trusted Results.
www.hearttronics.com, 20 Feb 2010 [cached]
Budimir S. Drakulic, Ph.D.
Heart Tronics, Inc. | Clear Data.
Budimir S. Drakulic, Ph.D.
Budimir S. Drakulic, PhD
Chief Technology Officer & Chief Scientist
Dr. Drakulic has 30 years of experience in the design and development of sophisticated hardware and software for biomedical microelectronic systems.
He was a Chief Scientist at Teledyne Electronics Technologies Medical Business Unit and a Director of Microelectronic Development Laboratory at Crump Institute for Medical Engineering at UCLA.
is the 1985 recipient of the Ralph and Marjorie Crump Prize for Excellence in Medical Engineering.
While at UCLA, Dr. Drakulic was a visiting Assistant Professor of the Electrical Engineering Department as well as the Department of Anatomy and Neurosurgery and a Research Fellow at the Crump Institute for Medical Engineering.